The Food and Drug Administration will take a second look at a weight-loss drug it rejected in 2010. The decision to review Qnexa comes as the agency is rethinking how it judges weight-loss drugs. Though obesity is at epidemic levels, the FDA hasn't
Read More...
Read the complete post at http://www.npr.org/blogs/health/2012/02/16/146988891/weight-loss-drugs-face-high-hurdles-at-fda?ft=1&f=103537970
Posted
Feb 16 2012, 11:59 PM
by
Shots - Health Blog